drugset / Trial / NCT05441267
A Study of Cardiovascular Events iN Diabetes Plus
RandomizedParallel-groupQuadruple-blindPrevention
Summary
ASCEND PLUS is testing whether, for people with type 2 diabetes who have not previously had a heart attack or stroke, regularly taking a tablet called semaglutide can safely help to reduce heart attacks, strokes, mini-strokes, the need for any procedures to unblock or bypass an artery to their heart, and the chance of dying because of vascular problems.
Timeline
- Start
- 2023-03-13
- Primary completion
- 2028-08-17
- Completion
- 2048-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Semaglutide | Peptide | 14 mg | Oral |